Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
11/09/1993 | US5260205 Anion exchange medium, elution |
11/09/1993 | US5260203 Computer based system determined chemical structure for converting two naturally aggregated but chemically separated light and heavy polpeptide chain into single chain having three dimensional structure |
11/09/1993 | US5259951 Passing solution of Factor VIII from human plasma through ion exchange chromatographic column using as equilibrating buffer and eluent high ionic strength saline solution at acid pH; stabilizers |
11/09/1993 | US5259939 Dynamic buffer coating |
11/09/1993 | CA1324095C Recombinant ricin toxin |
11/08/1993 | CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines |
11/07/1993 | CA2095577A1 Purification of plasminogen activator inhibitor 2 by immunoaffinity chromatography |
11/03/1993 | EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use |
11/03/1993 | EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS |
11/03/1993 | EP0477198B1 Method for recovering recombinant proteins |
11/03/1993 | EP0374182B1 Biospecific polymers |
11/03/1993 | EP0368864B1 Whey protein fractions |
11/03/1993 | CN1077961A Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds |
11/03/1993 | CN1077960A Hemoregulatory peptides |
11/02/1993 | US5258545 Amino acid derivative, method for preparing the same and method for preparing human osteocalcin using the same |
11/02/1993 | US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process |
11/02/1993 | US5258502 Immobilization and purification of fusion proteins using chitin-binding ability |
11/02/1993 | US5258501 Stabilization of glycoproteins |
11/02/1993 | US5258497 Process for purifying annexines |
11/02/1993 | US5258496 Precipitation and extraction of proteins |
11/02/1993 | US5258454 Solid phase synthesis of proteins with polystyrene grafted polymer substrate |
10/30/1993 | WO1993022682A1 In vitro test for helicobacter pylori |
10/28/1993 | WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins |
10/28/1993 | WO1993021224A1 Ultrapure human epidermal growth factor |
10/28/1993 | WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
10/28/1993 | WO1993021215A1 Peptides having tachykinin antagonist activity |
10/28/1993 | WO1993021207A1 Process for making vancomycin |
10/28/1993 | WO1993021206A1 Synthetic, stabilized, three-dimension polypeptides |
10/28/1993 | CA2118503A1 Peptides having tachykinin antagonist activity |
10/28/1993 | CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein |
10/28/1993 | CA2118028A1 Ultrapure human epidermal growth factor |
10/27/1993 | EP0567448A1 Factor VIII preparation |
10/27/1993 | EP0567088A2 Processes for the preparation of amylase inhibitor |
10/27/1993 | EP0566673A1 Biosynthetic pdgf antagonists |
10/27/1993 | EP0566647A1 Improved humanized immunoglobulins |
10/27/1993 | EP0431059B1 A method for carrying out organic chemical reactions and apparatus for carrying out that method |
10/27/1993 | CN1077715A Process for simultaneous renaturation and purification of denatured protein |
10/26/1993 | US5256769 Separating protein or its N-methionine analog from mixture utilizing difference in isoelectric points |
10/26/1993 | US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
10/26/1993 | US5256294 Tangential flow filtration process and apparatus |
10/26/1993 | CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
10/26/1993 | CA1323727C Glutamine-containing peptides, a process for the preparation thereof, and the use thereof |
10/26/1993 | CA1323726C Chromogenic compounds, a process for their preparation, and their use |
10/26/1993 | CA1323567C Method for purification of antibodies |
10/25/1993 | CA2094797A1 Method of treating and preventing viral infections using hbnf and mk protein |
10/20/1993 | EP0566459A1 Reagent and catalytic process for cleaving protected functional groups |
10/20/1993 | EP0566289A1 Analysis of hemoglobin variants by capillary electrophoresis |
10/20/1993 | EP0566066A1 Antigens of human non-small lung carcinoma |
10/20/1993 | EP0565607A1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
10/20/1993 | EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
10/20/1993 | EP0220241B1 Purified protein having angiogenic activity and methods of preparation |
10/19/1993 | US5254673 Purification of zein from corn gluten meal |
10/19/1993 | US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof |
10/19/1993 | US5254476 Method and system for analysis of peptides and proteins |
10/19/1993 | US5254475 Coupling to form a peptidylhydantoin derivative; cleaving |
10/18/1993 | CA2091944A1 Analysis of hemoglobin variants by capillary zone electrophoresis |
10/16/1993 | CA2093989A1 Reagent and catalytic process for clearing a protected function |
10/14/1993 | WO1993020442A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples |
10/14/1993 | WO1993020208A1 Methods for producing substantially pure eg iii cellulase using polyethylene glycol |
10/14/1993 | WO1993020100A1 Novel lipophilic oligopeptides with immunomodulating activity |
10/14/1993 | WO1993020098A1 Process for preparing modified proteins |
10/14/1993 | WO1993020079A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
10/14/1993 | WO1993020070A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels |
10/14/1993 | WO1993020064A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
10/14/1993 | WO1993020048A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels |
10/14/1993 | WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
10/14/1993 | CA2133569A1 Novel lipophilic oligopeptides with immunomodulating activity |
10/14/1993 | CA2132446A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
10/14/1993 | CA2132445A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels |
10/14/1993 | CA2132342A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
10/14/1993 | CA2132340A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivatives conjugates and labels |
10/14/1993 | CA2131727A1 Reagents and methods for the detection and quantification of thyroxine in fluid samples |
10/13/1993 | EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides |
10/13/1993 | EP0565148A2 Intermediates for preparation of H-Arg-X-Y-Z-Tyr-R |
10/13/1993 | EP0564739A2 Backbone cyclic peptides, processes for their preparation and pharmaceutical compositions containing them |
10/13/1993 | EP0564587A1 Solution phase process for synthesis of peptide |
10/13/1993 | EP0540687A4 Antibody-mediated cofactor-driven reactions |
10/13/1993 | EP0233197B1 Water soluble xanthylium derivative substrates |
10/13/1993 | CN1022412C Method for preparing urethane-protected amino acid-N-carboxyanhydrides |
10/12/1993 | US5252719 Process for preparing protein-oriented membrane |
10/12/1993 | US5252715 Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof |
10/12/1993 | US5252714 Preparation and use of polyethylene glycol propionaldehyde |
10/12/1993 | US5252710 Selective chromatographic separation of Factor VIII from von Willebrand factor; desorption, purification |
10/12/1993 | US5252709 Adjustment of ph of buffer |
10/12/1993 | US5252708 Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein |
10/12/1993 | US5252560 Cyclic imide derivatives, compositions and use |
10/12/1993 | US5252558 Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions |
10/12/1993 | US5252296 Method and apparatus for biopolymer synthesis |
10/12/1993 | US5252216 Using combination chromatography |
10/11/1993 | CA2093575A1 Human antithrombin iii mutant |
10/06/1993 | EP0563329A1 Angiogenic peptides |
10/06/1993 | EP0563302A1 Method and apparatus for granulation |
10/06/1993 | EP0563244A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
10/06/1993 | EP0563091A1 Vaccines based on hepatitis b surface antigen |
10/05/1993 | US5250665 Specifically β-β cross-linked hemoglobins and method of preparation |
10/05/1993 | US5250613 Solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor |
10/05/1993 | US5250516 Forming protective layer of thermoelastic polypeptide |
10/05/1993 | CA1322745C Porous wafer for segmented synthesis of biopolymers |
10/02/1993 | CA2093109A1 Morpholin- and thiomorpholin-4-ylamides |
10/02/1993 | CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |